{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:39:30Z","timestamp":1768034370530,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/pr.2017.179","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T12:00:51Z","timestamp":1500897651000},"page":"958-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity"],"prefix":"10.1038","volume":"82","author":[{"name":"on behalf of the REDEXAM study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"B\u00fchrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"Erdeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"van Kaam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Bar-Oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Stiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130stemi Han","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Berrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"issue":"Suppl 1","key":"BFpr2017179_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C . Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013;74 (Suppl 1): 35\u201349.","journal-title":"Pediatr Res"},{"key":"BFpr2017179_CR2","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1542\/peds.2014-0978","volume":"135","author":"WM Fierson","year":"2015","unstructured":"Fierson WM, Capone A Jr . American Academy of Pediatrics Section on Opthalmology, American Academy of Ophthalmology. Telemedicine for evaluation of retinopathy of prematurity. Pediatrics 2015;135:e238\u201354.","journal-title":"Pediatrics"},{"key":"BFpr2017179_CR3","doi-asserted-by":"publisher","first-page":"712624","DOI":"10.1155\/2015\/712624","volume":"2015","author":"LC Zepeda-Romero","year":"2015","unstructured":"Zepeda-Romero LC, Gilbert C . Limitations in ROP programs in 32 neonatal intensive care units in five states in Mexico. Biomed Res Int 2015;2015:712624.","journal-title":"Biomed Res Int"},{"key":"BFpr2017179_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/EB.S98715","volume":"8","author":"A Vinekar","year":"2016","unstructured":"Vinekar A, Jayadev C, Kumar S et al. Impact of improved neonatal care on the profile of retinopathy of prematurity in rural neonatal centers in India over a 4-year period. Eye Brain 2016;8:45\u201353.","journal-title":"Eye Brain"},{"key":"BFpr2017179_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00006982-200404000-00009","volume":"24","author":"R Rush","year":"2004","unstructured":"Rush R, Rush S, Nicolau J, Chapman K, Naqvi M . Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina 2004;24:242\u20135.","journal-title":"Retina"},{"key":"BFpr2017179_CR6","doi-asserted-by":"publisher","first-page":"F146","DOI":"10.1136\/adc.2009.168971","volume":"95","author":"CA Dhaliwal","year":"2010","unstructured":"Dhaliwal CA, Wright E, McIntosh N, Dhaliwal K, Fleck BW . Pain in neonates during screening for retinopathy of prematurity using binocular indirect ophthalmoscopy and wide-field digital retinal imaging: a randomised comparison. Arch Dis Child Fetal Neonatal Ed 2010;95:F146\u20138.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFpr2017179_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jaapos.2011.07.014","volume":"15","author":"AK Jensen","year":"2011","unstructured":"Jensen AK, Forbes BJ, Wilson LB, Prieto D, Binenbaum G . Widespread retinal hemorrhages after retinopathy of prematurity screening with scleral depression. J AAPOS 2011;15:609\u201311.","journal-title":"J AAPOS"},{"key":"BFpr2017179_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/jp.2012.149","volume":"33","author":"AM Cohen","year":"2013","unstructured":"Cohen AM, Cook N, Harris MC, Ying GS, Binenbaum G . The pain response to mydriatic eyedrops in preterm infants. J Perinatol 2013;33:462\u20135.","journal-title":"J Perinatol"},{"key":"BFpr2017179_CR9","doi-asserted-by":"publisher","first-page":"e1002","DOI":"10.1016\/j.jpeds.2015.07.050","volume":"167","author":"KC Wade","year":"2015","unstructured":"Wade KC, Pistilli M, Baumritter A et al. Safety of retinopathy of prematurity examination and imaging in premature infants. J Pediatr 2015;167:e1002.","journal-title":"J Pediatr"},{"key":"BFpr2017179_CR10","doi-asserted-by":"crossref","unstructured":"Agrawal Y, Patri S, Kalavakunta JK, Gupta V . Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure. Br Med J 2016;2016 pii: bcr2016216594.","DOI":"10.1136\/bcr-2016-216594"},{"key":"BFpr2017179_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.jp.7211199","volume":"25","author":"J Grabska","year":"2005","unstructured":"Grabska J, Walden P, Lerer T et al. Can oral sucrose reduce the pain and distress associated with screening for retinopathy of prematurity? J Perinatol 2005;25:33\u20135.","journal-title":"J Perinatol"},{"key":"BFpr2017179_CR12","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.cardfail.2005.04.009","volume":"11","author":"A Nir","year":"2005","unstructured":"Nir A, Nasser N . Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005;11:S76\u201380.","journal-title":"J Card Fail"},{"key":"BFpr2017179_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1253\/circj.CJ-09-0535","volume":"74","author":"M Sugimoto","year":"2010","unstructured":"Sugimoto M, Manabe H, Nakau K et al. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide. Circ J 2010;74:998\u20131005.","journal-title":"Circ J"},{"key":"BFpr2017179_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1203\/PDR.0b013e3181b3aee4","volume":"66","author":"E Lechner","year":"2009","unstructured":"Lechner E, Wiesinger-Eidenberger G, Wagner O et al. Amino terminal pro B-type natriuretic peptide levels are elevated in the cord blood of neonates with congenital heart defect. Pediatr Res 2009;66:466\u20139.","journal-title":"Pediatr Res"},{"key":"BFpr2017179_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1442-200X.2011.03417.x","volume":"53","author":"N Kurihara","year":"2011","unstructured":"Kurihara N, Miwa M, Matsuzaki Y et al. Usefulness of measurement of urinary N-terminal pro-brain natriuretic peptide in neonatal period. Pediatr Int 2011;53:608.","journal-title":"Pediatr Int"},{"key":"BFpr2017179_CR16","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1542\/peds.2014-1995","volume":"135","author":"M Kulkarni","year":"2015","unstructured":"Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M . Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review. Pediatrics 2015;135:e510\u201325.","journal-title":"Pediatrics"},{"key":"BFpr2017179_CR17","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1542\/peds.2011-0603","volume":"128","author":"C Czernik","year":"2011","unstructured":"Czernik C, Metze B, M\u00fcller C, M\u00fcller B, B\u00fchrer C . Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity. Pediatrics 2011;128:e545\u20139.","journal-title":"Pediatrics"},{"key":"BFpr2017179_CR18","doi-asserted-by":"crossref","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991\u2013999.","DOI":"10.1001\/archopht.123.7.991"},{"key":"BFpr2017179_CR19","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative Group","year":"2003","unstructured":"Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684\u201394.","journal-title":"Arch Ophthalmol"},{"key":"BFpr2017179_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaapos.2017.05.004","volume":"21","author":"JL Jung","year":"2017","unstructured":"Jung JL, Wagner BD, McCourt EA et al. Validation of WINROP for detecting retinopathy of prematurity in a North American cohort of preterm infants. J AAPOS 2017;21:229\u201333.","journal-title":"J AAPOS"},{"key":"BFpr2017179_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamaophthalmol.2016.5203","volume":"135","author":"J Gurwin","year":"2017","unstructured":"Gurwin J, Tomlinson LA, Quinn GE et al. A tiered approach to retinopathy of prematurity acreening (TARP) using a weight gain predictive model and a telemedicine system. JAMA Ophthalmol 2017;135:131\u2013136.","journal-title":"JAMA Ophthalmol"},{"key":"BFpr2017179_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/bjophthalmol-2013-303123","volume":"97","author":"AJ van Sorge","year":"2013","unstructured":"van Sorge AJ, Schalij-Delfos NE, Kerkhoff FT et al. Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria. Br J Ophthalmol 2013;97:1143\u20137.","journal-title":"Br J Ophthalmol"},{"key":"BFpr2017179_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/NPM-15814128","volume":"8","author":"K Thomas","year":"2015","unstructured":"Thomas K, Shah PS, Canning R, Harrison A, Lee SK, Dow KE . Retinopathy of prematurity: risk factors and variability in Canadian neonatal intensive care units. J Neonatal Perinatal Med 2015;8:207\u201314.","journal-title":"J Neonatal Perinatal Med"},{"key":"BFpr2017179_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ophtha.2015.12.019","volume":"123","author":"C Slidsborg","year":"2016","unstructured":"Slidsborg C, Jensen A, Forman JL et al. Neonatal risk factors for treatment-demanding retinopathy of prematurity: a Danish national study. Ophthalmology 2016;123:796\u2013803.","journal-title":"Ophthalmology"},{"key":"BFpr2017179_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jpeds.2013.11.015","volume":"164","author":"AJ van Sorge","year":"2014","unstructured":"van Sorge AJ, Termote JU, Kerkhoff FT et al. Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands. J Pediatr 2014;164:494\u20138.","journal-title":"J Pediatr"},{"key":"BFpr2017179_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/bjo.2003.025395","volume":"88","author":"K Allegaert","year":"2004","unstructured":"Allegaert K, Cossey V, Naulaers G, Vanhole C, Devlieger H, Casteels I . Dopamine is an indicator but not an independent risk factor for grade 3 retinopathy of prematurity in extreme low birthweight infants. Br J Ophthalmol 2004;88:309\u201310.","journal-title":"Br J Ophthalmol"},{"key":"BFpr2017179_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jpeds.2013.01.054","volume":"163","author":"M Catenacci","year":"2013","unstructured":"Catenacci M, Miyagi S, Wickremasinghe AC et al. Dopamine-resistant hypotension and severe retinopathy of prematurity. J Pediatr 2013;163:400\u20135.","journal-title":"J Pediatr"},{"key":"BFpr2017179_CR28","doi-asserted-by":"publisher","first-page":"e88781","DOI":"10.1371\/journal.pone.0088781","volume":"9","author":"A Perez-Mu\u00f1uzuri","year":"2014","unstructured":"Perez-Mu\u00f1uzuri A, Couce-Pico ML, Ba\u00f1a-Souto A et al. Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum. PLoS ONE 2014;9:e88781.","journal-title":"PLoS ONE"},{"key":"BFpr2017179_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jaapos.2014.02.012","volume":"18","author":"MA Hussein","year":"2014","unstructured":"Hussein MA, Coats DK, Khan H et al. Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity. J AAPOS 2014;18:332\u20137.","journal-title":"J AAPOS"},{"key":"BFpr2017179_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.104.472050","volume":"112","author":"M Brueckmann","year":"2005","unstructured":"Brueckmann M, Huhle G, Lang S et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005;112:527\u201334.","journal-title":"Circulation"},{"key":"BFpr2017179_CR31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/01.CCM.0000261893.72811.0F","volume":"35","author":"M Varpula","year":"2007","unstructured":"Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettila V . Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007;35:1277\u201383.","journal-title":"Crit Care Med"},{"key":"BFpr2017179_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1203\/PDR.0b013e318163a2e7","volume":"63","author":"ME van Albada","year":"2008","unstructured":"van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM . Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatr Res 2008;63:321\u20137.","journal-title":"Pediatr Res"},{"key":"BFpr2017179_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1537-2995.2008.01656.x","volume":"48","author":"AA Tobian","year":"2008","unstructured":"Tobian AA, Sokoll LJ, Tisch DJ, Ness PM, Shan H . N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008;48:1143\u201350.","journal-title":"Transfusion"},{"key":"BFpr2017179_CR34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/aos.12415","volume":"92","author":"V Aaltonen","year":"2014","unstructured":"Aaltonen V, Kinnunen K, Jouhilahti EM et al. Hypoxic conditions stimulate the release of B-type natriuretic peptide from human retinal pigment epithelium cell culture. Acta Ophthalmol 2014;92:740\u20134.","journal-title":"Acta Ophthalmol"},{"key":"BFpr2017179_CR35","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1167\/iovs.09-4905","volume":"51","author":"P Kozulin","year":"2010","unstructured":"Kozulin P, Natoli R, Bumsted O'Brien KM, Madigan MC, Provis JM . The cellular expression of antiangiogenic factors in fetal primate macula. Invest Ophthalmol Vis Sci 2010;51:4298\u2013306.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2017179_CR36","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.2337\/dc13-2625","volume":"37","author":"P Welsh","year":"2014","unstructured":"Welsh P, Woodward M, Hillis GS et al. Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial. Diabetes Care 2014;37:2202\u201310.","journal-title":"Diabetes Care"},{"key":"BFpr2017179_CR37","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/ATVBAHA.116.307545","volume":"36","author":"U Mutlu","year":"2016","unstructured":"Mutlu U, Ikram MA, Hofman A, de Jong PT, Klaver CC, Ikram MK . N-terminal pro-B-type natriuretic peptide is related to retinal microvascular damage: the Rotterdam study. Arterioscler Thromb Vasc Biol 2016;36:1698\u2013702.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFpr2017179_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2147\/VHRM.S67753","volume":"10","author":"K Hamano","year":"2014","unstructured":"Hamano K, Nakadaira I, Suzuki J, Gonai M . N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes. Vasc Health Risk Manag 2014;10:585\u20139.","journal-title":"Vasc Health Risk Manag"},{"issue":"10","key":"BFpr2017179_CR39","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/bjophthalmol-2016-310041","volume":"101","author":"Brian A Darlow","year":"2017","unstructured":"Darlow BA, Lui K, Kusuda S et al. International variations and trends in the treatment for retinopathy of prematurity. Br J Ophthalmol 2017 (e-pub ahead of print 7 March 2017; doi:10.1136\/bjophthalmol-2016-310041).","journal-title":"British Journal of Ophthalmology"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2017179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017179","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:02:59Z","timestamp":1684602179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2017179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFpr2017179"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.179","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]},"assertion":[{"value":"2 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}